Literature DB >> 27493022

Geographic access to interventional cardiology services in one rural state.

James P Rhudy1, Anne W Alexandrov2, Kristiina E Hyrkäs3, Rita A Jablonski-Jaudon4, Erica R Pryor4, Henry E Wang5, Marie A Bakitas4.   

Abstract

OBJECTIVES: Explore (1) the characteristics of the Maine population with delayed geographic access to interventional cardiology (IC) services and (2) the effect of delayed geographic IC access on coronary mortality.
BACKGROUND: Acute coronary syndrome (ACS), ST-segment elevated myocardial infarction (STEMI), and non-ST segment elevated myocardial infarction (NSTEMI) are highly prevalent. Coronary mortality is minimized when victims have prompt IC access.
METHODS: The study design was (1) an exploration of census data to investigate disparities in geographic IC access and (2) a secondary analysis of administrative claims data to investigate coronary mortality relative to delayed geographic IC access.
RESULTS: Delayed access was associated in the Maine population with rural residence, advanced age, high school education, and lack of health insurance. Delayed access was associated with increased unadjusted coronary mortality, but not age-adjusted coronary mortality.
CONCLUSION: Delayed geographic IC access was associated with disparity but not with increased age-adjusted coronary mortality.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Access to health care; Acute coronary syndrome; Geographic information system; Mortality; ST-Segment elevated myocardial infarction

Mesh:

Year:  2016        PMID: 27493022     DOI: 10.1016/j.hrtlng.2016.07.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  1 in total

1.  Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.

Authors:  Teppo Repo; Markku Tykkyläinen; Juha Mustonen; Tuomas T Rissanen; Matti Ketonen; Maija Toivakka; Tiina Laatikainen
Journal:  Int J Environ Res Public Health       Date:  2018-04-11       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.